STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism
Scientific meetings about Alzheimer’s disease can be funereal affairs. But this year's Clinical Trials in Alzheimer’s Disease meeting felt markedly different.
News
STAT+: Under new ownership, IBM Watson Health’s core assets get a rebranding
The IBM Watson Health brand comes with baggage. But for its new owners, the core assets are the primary selling point for a new business. […]
News
STAT+: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap
New legislation introduced by Sen. Bernie Sanders would prohibit all insulin manufacturers from charging more than $20 per vial. […]
News
STAT+: Pharmalittle: FDA approves a Genentech blood-cancer drug; Sean Parker expands his immunotherapy research empire
The FDA approved a new Genentech treatment for patients with follicular lymphoma, a slow-growing type of blood cancer. […]
